nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoprolol—SLC22A2—Cisplatin—bone cancer	0.361	0.56	CbGbCtD
Metoprolol—ABCB1—Cisplatin—bone cancer	0.096	0.149	CbGbCtD
Metoprolol—ABCB1—Doxorubicin—bone cancer	0.0643	0.0999	CbGbCtD
Metoprolol—ABCB1—Methotrexate—bone cancer	0.0623	0.0968	CbGbCtD
Metoprolol—CYP2D6—Doxorubicin—bone cancer	0.0606	0.0941	CbGbCtD
Metoprolol—Chlorphenesin—CYP3A4—bone cancer	0.00242	0.299	CrCbGaD
Metoprolol—Chlorphenesin—PTGS2—bone cancer	0.00237	0.293	CrCbGaD
Metoprolol—Bisoprolol—CYP3A4—bone cancer	0.00236	0.291	CrCbGaD
Metoprolol—Mood swings—Methotrexate—bone cancer	0.00116	0.00333	CcSEcCtD
Metoprolol—Anxiety—Cisplatin—bone cancer	0.00114	0.00328	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.00114	0.00327	CcSEcCtD
Metoprolol—Hot flush—Doxorubicin—bone cancer	0.00113	0.00326	CcSEcCtD
Metoprolol—Liver function test abnormal—Methotrexate—bone cancer	0.00113	0.00325	CcSEcCtD
Metoprolol—Affect lability—Epirubicin—bone cancer	0.00113	0.00324	CcSEcCtD
Metoprolol—Menopausal symptoms—Doxorubicin—bone cancer	0.00112	0.00323	CcSEcCtD
Metoprolol—Breast disorder—Methotrexate—bone cancer	0.00111	0.00318	CcSEcCtD
Metoprolol—Oedema—Cisplatin—bone cancer	0.0011	0.00315	CcSEcCtD
Metoprolol—Cardiac arrest—Epirubicin—bone cancer	0.00109	0.00313	CcSEcCtD
Metoprolol—Hypoglycaemia—Doxorubicin—bone cancer	0.00109	0.00312	CcSEcCtD
Metoprolol—Cardiac failure—Doxorubicin—bone cancer	0.00109	0.00312	CcSEcCtD
Metoprolol—Mood swings—Epirubicin—bone cancer	0.00109	0.00312	CcSEcCtD
Metoprolol—Cerebrovascular accident—Doxorubicin—bone cancer	0.00108	0.00311	CcSEcCtD
Metoprolol—Nervous system disorder—Cisplatin—bone cancer	0.00108	0.00309	CcSEcCtD
Metoprolol—Thrombocytopenia—Cisplatin—bone cancer	0.00107	0.00309	CcSEcCtD
Metoprolol—Tachycardia—Cisplatin—bone cancer	0.00107	0.00308	CcSEcCtD
Metoprolol—Skin disorder—Cisplatin—bone cancer	0.00107	0.00306	CcSEcCtD
Metoprolol—Hyperhidrosis—Cisplatin—bone cancer	0.00106	0.00305	CcSEcCtD
Metoprolol—Liver function test abnormal—Epirubicin—bone cancer	0.00106	0.00304	CcSEcCtD
Metoprolol—Orthostatic hypotension—Epirubicin—bone cancer	0.00105	0.00301	CcSEcCtD
Metoprolol—Abdominal pain upper—Epirubicin—bone cancer	0.00105	0.00301	CcSEcCtD
Metoprolol—Affect lability—Doxorubicin—bone cancer	0.00104	0.003	CcSEcCtD
Metoprolol—Breast disorder—Epirubicin—bone cancer	0.00104	0.00298	CcSEcCtD
Metoprolol—Hypotension—Cisplatin—bone cancer	0.00103	0.00295	CcSEcCtD
Metoprolol—Cardiac arrest—Doxorubicin—bone cancer	0.00101	0.0029	CcSEcCtD
Metoprolol—Mood swings—Doxorubicin—bone cancer	0.00101	0.00289	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Cisplatin—bone cancer	0.001	0.00287	CcSEcCtD
Metoprolol—Paraesthesia—Cisplatin—bone cancer	0.000985	0.00283	CcSEcCtD
Metoprolol—Liver function test abnormal—Doxorubicin—bone cancer	0.00098	0.00281	CcSEcCtD
Metoprolol—Dyspnoea—Cisplatin—bone cancer	0.000978	0.00281	CcSEcCtD
Metoprolol—Erectile dysfunction—Methotrexate—bone cancer	0.000975	0.0028	CcSEcCtD
Metoprolol—Orthostatic hypotension—Doxorubicin—bone cancer	0.000969	0.00278	CcSEcCtD
Metoprolol—Abdominal pain upper—Doxorubicin—bone cancer	0.000969	0.00278	CcSEcCtD
Metoprolol—Photosensitivity reaction—Methotrexate—bone cancer	0.000967	0.00278	CcSEcCtD
Metoprolol—Angina pectoris—Epirubicin—bone cancer	0.000965	0.00277	CcSEcCtD
Metoprolol—Breast disorder—Doxorubicin—bone cancer	0.000959	0.00275	CcSEcCtD
Metoprolol—Propranolol—CYP3A4—bone cancer	0.000951	0.118	CrCbGaD
Metoprolol—Pneumonia—Methotrexate—bone cancer	0.00095	0.00273	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Cisplatin—bone cancer	0.000948	0.00272	CcSEcCtD
Metoprolol—Depression—Methotrexate—bone cancer	0.000942	0.0027	CcSEcCtD
Metoprolol—Pain—Cisplatin—bone cancer	0.000939	0.0027	CcSEcCtD
Metoprolol—Conjunctivitis—Methotrexate—bone cancer	0.000918	0.00264	CcSEcCtD
Metoprolol—Sweating—Methotrexate—bone cancer	0.000905	0.0026	CcSEcCtD
Metoprolol—Photosensitivity reaction—Epirubicin—bone cancer	0.000905	0.0026	CcSEcCtD
Metoprolol—Feeling abnormal—Cisplatin—bone cancer	0.000904	0.0026	CcSEcCtD
Metoprolol—Weight increased—Epirubicin—bone cancer	0.000902	0.00259	CcSEcCtD
Metoprolol—Angina pectoris—Doxorubicin—bone cancer	0.000893	0.00257	CcSEcCtD
Metoprolol—Hepatobiliary disease—Methotrexate—bone cancer	0.000893	0.00257	CcSEcCtD
Metoprolol—Pneumonia—Epirubicin—bone cancer	0.000889	0.00255	CcSEcCtD
Metoprolol—Agranulocytosis—Methotrexate—bone cancer	0.000881	0.00253	CcSEcCtD
Metoprolol—Body temperature increased—Cisplatin—bone cancer	0.000868	0.00249	CcSEcCtD
Metoprolol—Jaundice—Epirubicin—bone cancer	0.000861	0.00247	CcSEcCtD
Metoprolol—Conjunctivitis—Epirubicin—bone cancer	0.000859	0.00247	CcSEcCtD
Metoprolol—Hepatitis—Methotrexate—bone cancer	0.000848	0.00244	CcSEcCtD
Metoprolol—Sweating—Epirubicin—bone cancer	0.000847	0.00243	CcSEcCtD
Metoprolol—Photosensitivity reaction—Doxorubicin—bone cancer	0.000837	0.0024	CcSEcCtD
Metoprolol—Hepatobiliary disease—Epirubicin—bone cancer	0.000836	0.0024	CcSEcCtD
Metoprolol—Weight increased—Doxorubicin—bone cancer	0.000835	0.0024	CcSEcCtD
Metoprolol—Agranulocytosis—Epirubicin—bone cancer	0.000825	0.00237	CcSEcCtD
Metoprolol—Pneumonia—Doxorubicin—bone cancer	0.000822	0.00236	CcSEcCtD
Metoprolol—Visual impairment—Methotrexate—bone cancer	0.000817	0.00235	CcSEcCtD
Metoprolol—Hypersensitivity—Cisplatin—bone cancer	0.000809	0.00232	CcSEcCtD
Metoprolol—Bradycardia—Epirubicin—bone cancer	0.000808	0.00232	CcSEcCtD
Metoprolol—Jaundice—Doxorubicin—bone cancer	0.000797	0.00229	CcSEcCtD
Metoprolol—Rhinitis—Epirubicin—bone cancer	0.000795	0.00228	CcSEcCtD
Metoprolol—Conjunctivitis—Doxorubicin—bone cancer	0.000795	0.00228	CcSEcCtD
Metoprolol—Hepatitis—Epirubicin—bone cancer	0.000793	0.00228	CcSEcCtD
Metoprolol—Eye disorder—Methotrexate—bone cancer	0.000792	0.00228	CcSEcCtD
Metoprolol—Tinnitus—Methotrexate—bone cancer	0.00079	0.00227	CcSEcCtD
Metoprolol—Asthenia—Cisplatin—bone cancer	0.000787	0.00226	CcSEcCtD
Metoprolol—Cardiac disorder—Methotrexate—bone cancer	0.000787	0.00226	CcSEcCtD
Metoprolol—Sweating—Doxorubicin—bone cancer	0.000784	0.00225	CcSEcCtD
Metoprolol—Oedema peripheral—Epirubicin—bone cancer	0.000781	0.00225	CcSEcCtD
Metoprolol—Connective tissue disorder—Epirubicin—bone cancer	0.00078	0.00224	CcSEcCtD
Metoprolol—Hepatobiliary disease—Doxorubicin—bone cancer	0.000773	0.00222	CcSEcCtD
Metoprolol—Angiopathy—Methotrexate—bone cancer	0.000769	0.00221	CcSEcCtD
Metoprolol—Immune system disorder—Methotrexate—bone cancer	0.000766	0.0022	CcSEcCtD
Metoprolol—Visual impairment—Epirubicin—bone cancer	0.000764	0.0022	CcSEcCtD
Metoprolol—Mediastinal disorder—Methotrexate—bone cancer	0.000764	0.00219	CcSEcCtD
Metoprolol—Agranulocytosis—Doxorubicin—bone cancer	0.000763	0.00219	CcSEcCtD
Metoprolol—Diarrhoea—Cisplatin—bone cancer	0.000751	0.00216	CcSEcCtD
Metoprolol—Alopecia—Methotrexate—bone cancer	0.000749	0.00215	CcSEcCtD
Metoprolol—Bradycardia—Doxorubicin—bone cancer	0.000747	0.00215	CcSEcCtD
Metoprolol—Mental disorder—Methotrexate—bone cancer	0.000743	0.00213	CcSEcCtD
Metoprolol—Eye disorder—Epirubicin—bone cancer	0.000741	0.00213	CcSEcCtD
Metoprolol—Tinnitus—Epirubicin—bone cancer	0.00074	0.00212	CcSEcCtD
Metoprolol—Cardiac disorder—Epirubicin—bone cancer	0.000736	0.00212	CcSEcCtD
Metoprolol—Rhinitis—Doxorubicin—bone cancer	0.000736	0.00211	CcSEcCtD
Metoprolol—Hepatitis—Doxorubicin—bone cancer	0.000734	0.00211	CcSEcCtD
Metoprolol—Oedema peripheral—Doxorubicin—bone cancer	0.000723	0.00208	CcSEcCtD
Metoprolol—Dysgeusia—Methotrexate—bone cancer	0.000723	0.00208	CcSEcCtD
Metoprolol—Connective tissue disorder—Doxorubicin—bone cancer	0.000721	0.00207	CcSEcCtD
Metoprolol—Angiopathy—Epirubicin—bone cancer	0.00072	0.00207	CcSEcCtD
Metoprolol—Immune system disorder—Epirubicin—bone cancer	0.000717	0.00206	CcSEcCtD
Metoprolol—Mediastinal disorder—Epirubicin—bone cancer	0.000715	0.00205	CcSEcCtD
Metoprolol—Arrhythmia—Epirubicin—bone cancer	0.000709	0.00204	CcSEcCtD
Metoprolol—Visual impairment—Doxorubicin—bone cancer	0.000707	0.00203	CcSEcCtD
Metoprolol—Alopecia—Epirubicin—bone cancer	0.000701	0.00201	CcSEcCtD
Metoprolol—Vomiting—Cisplatin—bone cancer	0.000698	0.002	CcSEcCtD
Metoprolol—Vision blurred—Methotrexate—bone cancer	0.000695	0.002	CcSEcCtD
Metoprolol—Mental disorder—Epirubicin—bone cancer	0.000695	0.002	CcSEcCtD
Metoprolol—Rash—Cisplatin—bone cancer	0.000692	0.00199	CcSEcCtD
Metoprolol—Dermatitis—Cisplatin—bone cancer	0.000691	0.00199	CcSEcCtD
Metoprolol—Eye disorder—Doxorubicin—bone cancer	0.000686	0.00197	CcSEcCtD
Metoprolol—Tinnitus—Doxorubicin—bone cancer	0.000684	0.00197	CcSEcCtD
Metoprolol—Cardiac disorder—Doxorubicin—bone cancer	0.000681	0.00196	CcSEcCtD
Metoprolol—Flatulence—Epirubicin—bone cancer	0.00068	0.00195	CcSEcCtD
Metoprolol—Tension—Epirubicin—bone cancer	0.000678	0.00195	CcSEcCtD
Metoprolol—Dysgeusia—Epirubicin—bone cancer	0.000676	0.00194	CcSEcCtD
Metoprolol—Nervousness—Epirubicin—bone cancer	0.000671	0.00193	CcSEcCtD
Metoprolol—Angiopathy—Doxorubicin—bone cancer	0.000666	0.00191	CcSEcCtD
Metoprolol—Muscle spasms—Epirubicin—bone cancer	0.000664	0.00191	CcSEcCtD
Metoprolol—Immune system disorder—Doxorubicin—bone cancer	0.000663	0.0019	CcSEcCtD
Metoprolol—Vertigo—Methotrexate—bone cancer	0.000663	0.0019	CcSEcCtD
Metoprolol—Mediastinal disorder—Doxorubicin—bone cancer	0.000662	0.0019	CcSEcCtD
Metoprolol—Leukopenia—Methotrexate—bone cancer	0.000661	0.0019	CcSEcCtD
Metoprolol—Arrhythmia—Doxorubicin—bone cancer	0.000656	0.00188	CcSEcCtD
Metoprolol—Nausea—Cisplatin—bone cancer	0.000652	0.00187	CcSEcCtD
Metoprolol—Vision blurred—Epirubicin—bone cancer	0.000651	0.00187	CcSEcCtD
Metoprolol—Alopecia—Doxorubicin—bone cancer	0.000649	0.00186	CcSEcCtD
Metoprolol—Mental disorder—Doxorubicin—bone cancer	0.000643	0.00185	CcSEcCtD
Metoprolol—Flatulence—Doxorubicin—bone cancer	0.00063	0.00181	CcSEcCtD
Metoprolol—Arthralgia—Methotrexate—bone cancer	0.000628	0.0018	CcSEcCtD
Metoprolol—Chest pain—Methotrexate—bone cancer	0.000628	0.0018	CcSEcCtD
Metoprolol—Tension—Doxorubicin—bone cancer	0.000627	0.0018	CcSEcCtD
Metoprolol—Dysgeusia—Doxorubicin—bone cancer	0.000626	0.0018	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000624	0.00179	CcSEcCtD
Metoprolol—Nervousness—Doxorubicin—bone cancer	0.000621	0.00178	CcSEcCtD
Metoprolol—Vertigo—Epirubicin—bone cancer	0.00062	0.00178	CcSEcCtD
Metoprolol—Syncope—Epirubicin—bone cancer	0.000619	0.00178	CcSEcCtD
Metoprolol—Leukopenia—Epirubicin—bone cancer	0.000618	0.00178	CcSEcCtD
Metoprolol—Muscle spasms—Doxorubicin—bone cancer	0.000614	0.00176	CcSEcCtD
Metoprolol—Palpitations—Epirubicin—bone cancer	0.00061	0.00175	CcSEcCtD
Metoprolol—Confusional state—Methotrexate—bone cancer	0.000607	0.00174	CcSEcCtD
Metoprolol—Loss of consciousness—Epirubicin—bone cancer	0.000607	0.00174	CcSEcCtD
Metoprolol—Vision blurred—Doxorubicin—bone cancer	0.000602	0.00173	CcSEcCtD
Metoprolol—Hypertension—Epirubicin—bone cancer	0.000596	0.00171	CcSEcCtD
Metoprolol—Nervous system disorder—Methotrexate—bone cancer	0.000591	0.0017	CcSEcCtD
Metoprolol—Thrombocytopenia—Methotrexate—bone cancer	0.00059	0.00169	CcSEcCtD
Metoprolol—Arthralgia—Epirubicin—bone cancer	0.000588	0.00169	CcSEcCtD
Metoprolol—Chest pain—Epirubicin—bone cancer	0.000588	0.00169	CcSEcCtD
Metoprolol—Anxiety—Epirubicin—bone cancer	0.000586	0.00168	CcSEcCtD
Metoprolol—Skin disorder—Methotrexate—bone cancer	0.000585	0.00168	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000584	0.00168	CcSEcCtD
Metoprolol—Hyperhidrosis—Methotrexate—bone cancer	0.000582	0.00167	CcSEcCtD
Metoprolol—Dry mouth—Epirubicin—bone cancer	0.000575	0.00165	CcSEcCtD
Metoprolol—Vertigo—Doxorubicin—bone cancer	0.000574	0.00165	CcSEcCtD
Metoprolol—Syncope—Doxorubicin—bone cancer	0.000573	0.00165	CcSEcCtD
Metoprolol—Leukopenia—Doxorubicin—bone cancer	0.000572	0.00164	CcSEcCtD
Metoprolol—Confusional state—Epirubicin—bone cancer	0.000568	0.00163	CcSEcCtD
Metoprolol—Palpitations—Doxorubicin—bone cancer	0.000565	0.00162	CcSEcCtD
Metoprolol—Oedema—Epirubicin—bone cancer	0.000564	0.00162	CcSEcCtD
Metoprolol—Hypotension—Methotrexate—bone cancer	0.000563	0.00162	CcSEcCtD
Metoprolol—Loss of consciousness—Doxorubicin—bone cancer	0.000562	0.00161	CcSEcCtD
Metoprolol—Shock—Epirubicin—bone cancer	0.000554	0.00159	CcSEcCtD
Metoprolol—Nervous system disorder—Epirubicin—bone cancer	0.000553	0.00159	CcSEcCtD
Metoprolol—Thrombocytopenia—Epirubicin—bone cancer	0.000552	0.00159	CcSEcCtD
Metoprolol—Hypertension—Doxorubicin—bone cancer	0.000552	0.00158	CcSEcCtD
Metoprolol—Tachycardia—Epirubicin—bone cancer	0.00055	0.00158	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000549	0.00158	CcSEcCtD
Metoprolol—Skin disorder—Epirubicin—bone cancer	0.000547	0.00157	CcSEcCtD
Metoprolol—Hyperhidrosis—Epirubicin—bone cancer	0.000545	0.00157	CcSEcCtD
Metoprolol—Insomnia—Methotrexate—bone cancer	0.000545	0.00156	CcSEcCtD
Metoprolol—Arthralgia—Doxorubicin—bone cancer	0.000544	0.00156	CcSEcCtD
Metoprolol—Chest pain—Doxorubicin—bone cancer	0.000544	0.00156	CcSEcCtD
Metoprolol—Anxiety—Doxorubicin—bone cancer	0.000542	0.00156	CcSEcCtD
Metoprolol—Paraesthesia—Methotrexate—bone cancer	0.000541	0.00155	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.00054	0.00155	CcSEcCtD
Metoprolol—Dyspnoea—Methotrexate—bone cancer	0.000537	0.00154	CcSEcCtD
Metoprolol—Somnolence—Methotrexate—bone cancer	0.000535	0.00154	CcSEcCtD
Metoprolol—Dry mouth—Doxorubicin—bone cancer	0.000532	0.00153	CcSEcCtD
Metoprolol—Dyspepsia—Methotrexate—bone cancer	0.00053	0.00152	CcSEcCtD
Metoprolol—Hypotension—Epirubicin—bone cancer	0.000527	0.00151	CcSEcCtD
Metoprolol—Confusional state—Doxorubicin—bone cancer	0.000526	0.00151	CcSEcCtD
Metoprolol—Oedema—Doxorubicin—bone cancer	0.000521	0.0015	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Methotrexate—bone cancer	0.00052	0.00149	CcSEcCtD
Metoprolol—Fatigue—Methotrexate—bone cancer	0.000519	0.00149	CcSEcCtD
Metoprolol—Pain—Methotrexate—bone cancer	0.000515	0.00148	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000513	0.00148	CcSEcCtD
Metoprolol—Shock—Doxorubicin—bone cancer	0.000513	0.00147	CcSEcCtD
Metoprolol—Nervous system disorder—Doxorubicin—bone cancer	0.000511	0.00147	CcSEcCtD
Metoprolol—Thrombocytopenia—Doxorubicin—bone cancer	0.000511	0.00147	CcSEcCtD
Metoprolol—Insomnia—Epirubicin—bone cancer	0.00051	0.00146	CcSEcCtD
Metoprolol—Tachycardia—Doxorubicin—bone cancer	0.000509	0.00146	CcSEcCtD
Metoprolol—Skin disorder—Doxorubicin—bone cancer	0.000507	0.00146	CcSEcCtD
Metoprolol—Paraesthesia—Epirubicin—bone cancer	0.000506	0.00145	CcSEcCtD
Metoprolol—Hyperhidrosis—Doxorubicin—bone cancer	0.000504	0.00145	CcSEcCtD
Metoprolol—Dyspnoea—Epirubicin—bone cancer	0.000502	0.00144	CcSEcCtD
Metoprolol—Somnolence—Epirubicin—bone cancer	0.000501	0.00144	CcSEcCtD
Metoprolol—Feeling abnormal—Methotrexate—bone cancer	0.000496	0.00143	CcSEcCtD
Metoprolol—Dyspepsia—Epirubicin—bone cancer	0.000496	0.00143	CcSEcCtD
Metoprolol—Gastrointestinal pain—Methotrexate—bone cancer	0.000492	0.00141	CcSEcCtD
Metoprolol—Hypotension—Doxorubicin—bone cancer	0.000487	0.0014	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Epirubicin—bone cancer	0.000487	0.0014	CcSEcCtD
Metoprolol—Fatigue—Epirubicin—bone cancer	0.000486	0.0014	CcSEcCtD
Metoprolol—Pain—Epirubicin—bone cancer	0.000482	0.00138	CcSEcCtD
Metoprolol—Constipation—Epirubicin—bone cancer	0.000482	0.00138	CcSEcCtD
Metoprolol—Urticaria—Methotrexate—bone cancer	0.000478	0.00137	CcSEcCtD
Metoprolol—Abdominal pain—Methotrexate—bone cancer	0.000476	0.00137	CcSEcCtD
Metoprolol—Body temperature increased—Methotrexate—bone cancer	0.000476	0.00137	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000475	0.00136	CcSEcCtD
Metoprolol—Insomnia—Doxorubicin—bone cancer	0.000472	0.00136	CcSEcCtD
Metoprolol—Paraesthesia—Doxorubicin—bone cancer	0.000468	0.00135	CcSEcCtD
Metoprolol—Dyspnoea—Doxorubicin—bone cancer	0.000465	0.00134	CcSEcCtD
Metoprolol—Feeling abnormal—Epirubicin—bone cancer	0.000464	0.00133	CcSEcCtD
Metoprolol—Somnolence—Doxorubicin—bone cancer	0.000464	0.00133	CcSEcCtD
Metoprolol—Gastrointestinal pain—Epirubicin—bone cancer	0.000461	0.00132	CcSEcCtD
Metoprolol—Dyspepsia—Doxorubicin—bone cancer	0.000459	0.00132	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Doxorubicin—bone cancer	0.00045	0.00129	CcSEcCtD
Metoprolol—Fatigue—Doxorubicin—bone cancer	0.00045	0.00129	CcSEcCtD
Metoprolol—Urticaria—Epirubicin—bone cancer	0.000448	0.00129	CcSEcCtD
Metoprolol—Constipation—Doxorubicin—bone cancer	0.000446	0.00128	CcSEcCtD
Metoprolol—Pain—Doxorubicin—bone cancer	0.000446	0.00128	CcSEcCtD
Metoprolol—Body temperature increased—Epirubicin—bone cancer	0.000446	0.00128	CcSEcCtD
Metoprolol—Abdominal pain—Epirubicin—bone cancer	0.000446	0.00128	CcSEcCtD
Metoprolol—Hypersensitivity—Methotrexate—bone cancer	0.000444	0.00127	CcSEcCtD
Metoprolol—Asthenia—Methotrexate—bone cancer	0.000432	0.00124	CcSEcCtD
Metoprolol—Feeling abnormal—Doxorubicin—bone cancer	0.00043	0.00123	CcSEcCtD
Metoprolol—Gastrointestinal pain—Doxorubicin—bone cancer	0.000426	0.00123	CcSEcCtD
Metoprolol—Pruritus—Methotrexate—bone cancer	0.000426	0.00122	CcSEcCtD
Metoprolol—Hypersensitivity—Epirubicin—bone cancer	0.000415	0.00119	CcSEcCtD
Metoprolol—Urticaria—Doxorubicin—bone cancer	0.000414	0.00119	CcSEcCtD
Metoprolol—Abdominal pain—Doxorubicin—bone cancer	0.000412	0.00118	CcSEcCtD
Metoprolol—Body temperature increased—Doxorubicin—bone cancer	0.000412	0.00118	CcSEcCtD
Metoprolol—Diarrhoea—Methotrexate—bone cancer	0.000412	0.00118	CcSEcCtD
Metoprolol—Asthenia—Epirubicin—bone cancer	0.000404	0.00116	CcSEcCtD
Metoprolol—Pruritus—Epirubicin—bone cancer	0.000399	0.00115	CcSEcCtD
Metoprolol—Dizziness—Methotrexate—bone cancer	0.000398	0.00114	CcSEcCtD
Metoprolol—Diarrhoea—Epirubicin—bone cancer	0.000386	0.00111	CcSEcCtD
Metoprolol—Hypersensitivity—Doxorubicin—bone cancer	0.000384	0.0011	CcSEcCtD
Metoprolol—Vomiting—Methotrexate—bone cancer	0.000383	0.0011	CcSEcCtD
Metoprolol—Rash—Methotrexate—bone cancer	0.00038	0.00109	CcSEcCtD
Metoprolol—Dermatitis—Methotrexate—bone cancer	0.000379	0.00109	CcSEcCtD
Metoprolol—Headache—Methotrexate—bone cancer	0.000377	0.00108	CcSEcCtD
Metoprolol—Asthenia—Doxorubicin—bone cancer	0.000374	0.00107	CcSEcCtD
Metoprolol—Dizziness—Epirubicin—bone cancer	0.000373	0.00107	CcSEcCtD
Metoprolol—Pruritus—Doxorubicin—bone cancer	0.000369	0.00106	CcSEcCtD
Metoprolol—Vomiting—Epirubicin—bone cancer	0.000358	0.00103	CcSEcCtD
Metoprolol—Nausea—Methotrexate—bone cancer	0.000358	0.00103	CcSEcCtD
Metoprolol—Diarrhoea—Doxorubicin—bone cancer	0.000357	0.00103	CcSEcCtD
Metoprolol—Rash—Epirubicin—bone cancer	0.000355	0.00102	CcSEcCtD
Metoprolol—Dermatitis—Epirubicin—bone cancer	0.000355	0.00102	CcSEcCtD
Metoprolol—Headache—Epirubicin—bone cancer	0.000353	0.00101	CcSEcCtD
Metoprolol—Dizziness—Doxorubicin—bone cancer	0.000345	0.000991	CcSEcCtD
Metoprolol—Nausea—Epirubicin—bone cancer	0.000335	0.000962	CcSEcCtD
Metoprolol—Vomiting—Doxorubicin—bone cancer	0.000332	0.000953	CcSEcCtD
Metoprolol—Rash—Doxorubicin—bone cancer	0.000329	0.000945	CcSEcCtD
Metoprolol—Dermatitis—Doxorubicin—bone cancer	0.000329	0.000944	CcSEcCtD
Metoprolol—Headache—Doxorubicin—bone cancer	0.000327	0.000939	CcSEcCtD
Metoprolol—Nausea—Doxorubicin—bone cancer	0.00031	0.00089	CcSEcCtD
